Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 11:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Gestational Hypertension, Toxemia, Superimposed Preeclampsia, Eclampsia, HELLP Syndrome
Interventions: Vitamin D3; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 412 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Lung Diseases, Sleep Apnea Syndromes, Hypertension
Interventions: Continuous Positive Airway Pressure (CPAP) Treatment, Sham CPAP device - CPAP device with pressure delivered <1 cm H20; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 100 Years
Enrollment: 281 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 4
States / cities: Denver, Colorado • Atlanta, Georgia • Long Island City, New York + 1 more

Conditions: Glaucoma, Quality of Life
Interventions: Clinical evaluation, Performance based measures, Subjective measures of vision-related quality of life; Other
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years to 80 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: optima4BP Medication Management; Device
Lead sponsor: Optima Integrated Health; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Carlos, California

Conditions: Pulmonary Arterial Hypertension
Interventions: Ranolazine, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 72 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obstructive Sleep Apnea, Pregnancy, Obesity, Preeclampsia, Sleep
Interventions: Positive Airway Pressure, Nasal Dilator Strips; Device · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: High Blood Pressure, Liver Transplant, Renal Function Abnormal
Interventions: Amlodipine Besylate, Chlorthalidone; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: Amlodipine, Olmesartan medoxomil plus amlodipine; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 18
States / cities: Buena Park, California • Long Beach, California • Los Angeles, California + 15 more

Conditions: Pulmonary Hypertension
Interventions: TNX-103, Placebo; Drug
Lead sponsor: Tenax Therapeutics, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 40
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 32 more

Conditions: Hypertension
Interventions: Enhanced External Counterpulsation; Device
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: Metoprolol, Nebivolol; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Essential Hypertension
Interventions: XOMA 985, Amlodipine Besylate, Perindopril Erbumine; Drug
Lead sponsor: Symplmed Pharmaceuticals LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 837 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 48
States / cities: Huntsville, Alabama • Muscle Shoals, Alabama • Glendale, Arizona + 45 more

Conditions: Hypertension
Interventions: COREG CR and lisinopril (FDC); Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Hypertension
Interventions: Dihydropyridine calcium channel blocker, Hydrochlorothiazide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 65 Years and older
Enrollment: 163,720 participants
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Brain Injury, Intracranial Hypertension
Interventions: Chest Physiotherapy; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 3
States / cities: Mission Viejo, California • Durham, North Carolina • Raleigh, North Carolina

Conditions: Perioperative Bleeding, Venous Thrombosis, Arterial Thrombosis
Interventions: Tranexamic Acid, Placebo (Saline), Perioperative hypotension-avoidance strategy, Perioperative hypertension-avoidance strategy; Drug · Other
Lead sponsor: Population Health Research Institute; Other
Eligibility: 45 Years and older
Enrollment: 9,535 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 12
States / cities: New Haven, Connecticut • Weston, Florida • New York, New York + 8 more

Conditions: Glaucoma, Visual Field Defect
Interventions: Visual Field Perimeter Optimized with Eye Gaze Capture and Artificial Intelligence; Device
Lead sponsor: Sight Intelligence Engineering Corporation; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Type 2, Diabetes Mellitus, Coronary Disease
Interventions: Anti-hyperglycemic Agents, Anti-hypertensive Agents, Blinded fenofibrate or placebo plus simvastatin; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 40 Years to 79 Years
Enrollment: 10,251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2012
U.S. locations: 6
States / cities: Minneapolis, Minnesota • New York, New York • Winston-Salem, North Carolina + 3 more

Conditions: Venous Thromboembolism
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Up to 21 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis
Interventions: belapectin, Placebo; Drug
Lead sponsor: Galectin Therapeutics Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 81
States / cities: Birmingham, Alabama • Dothan, Alabama • Chandler, Arizona + 69 more

Conditions: Glaucoma
Interventions: Prostaglandin Analogue -Containing IOP-Lowering Therapy, Beta Blocker, Brillouin Microscopy; Drug · Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Blood Pressure, Hypertension, Cancer, Cancer, Breast, Cancer of Prostate, Cancer Colorectal, Cancer, Endometrial, Cancer of Head and Neck, Non Small Cell Lung Cancer, CVD - Cardiovascular Disease, Diabetes Mellitus, Hypercholesterolemia, Diabetes, Cancer of Esophagus, Cancer of Liver, Cancer, Renal Cell, Cancer of Pancreas, Cancer Ovaries
Interventions: iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted), Control; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Diseases, Diabetes, Gestational Diabetes, Preeclampsia, Gestational Hypertension, Small for Gestational Age at Delivery, Preterm Birth, Overweight and Obesity
Interventions: Fit After Baby, Text4Baby Control Group; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension, Pulmonary
Interventions: Not listed
Lead sponsor: Association for Pediatric Pulmonary Hypertension; Other
Eligibility: 3 Months to 18 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 13
States / cities: Palo Alto, California • Aurora, Colorado • Washington D.C., District of Columbia + 10 more

Search by objective public record fields.

A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea

How Has Glaucoma Affected Your Quality of Life?

Piloting Healthcare Coordination in Hypertension

A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension

Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension

Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate

Perindopril Amlodipine for the Treatment of Hypertension

Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide

Automated Chest Physiotherapy to Improve Outcomes in Neuro

PeriOperative ISchemic Evaluation-3 Trial

Visual Field Analysis With Artificial Intelligence

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Thrombosis Outcomes in Pediatric Venous Thromboembolism

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Onco-primary Care Networking to Support TEAM-based Care

Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease

Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension